Large pharmaceutical companies say allowing Medicare to negotiate lower drug prices will stifle innovation in drug development. Read a new op-ed in Harvard Business Review to find out why that’s not so.
Consulting Writer and Editor, Pear Tree Communications
Martha Hostetter is a partner in Pear Tree Communications. She is currently a consulting writer and editor for the Fund, and a contributing editor for the Fund's quarterly newsletter,Transforming Care. She was a member of the Commonwealth Fund's communications department from June 2002 to April 2005, serving as the associate editor and then creating the position of Web editor. Ms. Hostetter has an M.F.A. from Yale University and a B.A. from the University of Pennsylvania.